FTI Consulting
FTI CONSULTING, INC
Key figures
Period Jan 2025 to Dec 2025ConsolidatedU.S. GAAP
RevenueDisclosed
US$3.8B
Operating marginCalculated
10.3%
Net assets to total assetsCalculated
49.7%
Company profile
Tables scroll sideways
Disclosed data
Profitability
★★★☆☆position among all companies
10.3%
Growth (revenue, 4-year average)
★★★★☆position among all companies
8.1%
Capital efficiency
★★★★☆position among all companies
15.6%
Revenue and profit
Performance, financial position and capital allocation
FTI Consulting
Recent performance trends
FTI Consulting
Cash flow trends
Consolidated indicators (9 items)
| Item | 4 years ago | 3 years ago | 2 years ago | Last year | This year |
|---|---|---|---|---|---|
| Net sales | US$2.8 billion | US$3.0 billion | US$3.5 billion | US$3.7 billion | US$3.8 billion |
| Operating income | US$0.3 billion | US$0.3 billion | US$0.4 billion | US$0.3 billion | US$0.4 billion |
| Net income | US$0.2 billion | US$0.2 billion | US$0.3 billion | US$0.3 billion | US$0.3 billion |
| Total assets | US$3.1 billion | US$3.2 billion | US$3.3 billion | US$3.6 billion | US$3.5 billion |
| Shareholders' equity | US$1.6 billion | US$1.7 billion | US$2.0 billion | US$2.3 billion | US$1.7 billion |
| Net cash provided by (used in) operating activities | US$0.4 billion | US$0.2 billion | US$0.2 billion | US$0.4 billion | US$0.2 billion |
| Net cash provided by (used in) investing activities | US$-79.09 million | US$-60.06 million | US$-73.83 million | US$-10.16 million | US$-58.53 million |
| Net cash provided by (used in) financing activities | US$-61.67 million | US$-0.1 billion | US$-0.4 billion | US$-15.38 million | US$-0.5 billion |
| Cash and cash equivalents | US$0.5 billion | US$0.5 billion | US$0.3 billion | US$0.7 billion | US$0.3 billion |
Revenue scale in the same industry
FTI Consulting
Engineering, accounting, research and management services: 11 companies · revenue · largest first・each company’s latest fiscal year・Consolidated・Disclosed
- 1 Iqvia HoldingsFY Dec 2025 US$16.3B
- 2 AecomFY Sep 2025 US$16.1B
- 3 Booz Allen Hamilton HoldingFY Mar 2026 US$11.2B
- … 4 companies
- 8 V2XFY Dec 2025 US$4.5B
- 9 Charles River Laboratories InternationalFY Dec 2025 US$4.0B
- 10 FTI ConsultingThis companyFY Dec 2025 US$3.8B
- 11 Astrana HealthFY Dec 2025 US$3.2B
Sources and methodology
Basic indicators
| Item | Value | Consolidated / Non-consolidated | Source |
|---|---|---|---|
| Purchase of property, plant and equipment | US$58.53 million | Consolidated | Disclosed |
| Cash and cash equivalents | US$0.3 billion | Consolidated | Disclosed |
| Net cash provided by (used in) financing activities | US$-0.5 billion | Consolidated | Disclosed |
| Net cash provided by (used in) investing activities | US$-58.53 million | Consolidated | Disclosed |
| Net cash provided by (used in) operating activities | US$0.2 billion | Consolidated | Disclosed |
| Depreciation and amortization | US$45.76 million | Consolidated | Disclosed |
| Net assets | US$1.7 billion | Consolidated | Disclosed |
| Net sales | US$3.8 billion | Consolidated | Disclosed |
| Operating income | US$0.4 billion | Consolidated | Disclosed |
| Net income | US$0.3 billion | Consolidated | Disclosed |
| Total assets | US$3.5 billion | Consolidated | Disclosed |
| Purchase of treasury stock | US$0.9 billion | Consolidated | Disclosed |
| Operating margin | 10.3% | Consolidated | Calculated |
| Net assets to total assets | 49.7% | Consolidated | Calculated |
| Net margin | 7.1% | Consolidated | Calculated |
| Return on equity | 15.6% | Consolidated | Calculated |